All Search Results

Displaying Results "synthetic biology"

News Releases

Apr 09, 2026, 08:15 ET Mimulus and GenScript Partner to Scale the World's First Zero-Watt Molecular Archive Infrastructure for the AI Era

Archive Technology™ and zero-watt Glacier Data Storage Cards, Mimulus combines the scaling laws of the semiconductor industry with the density of synthetic biology to solve the global archival storage crisis and liberate critical grid power for AI compute. Mimulus is making the future molecular. For more

More news about: Mimulus Corp


Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era

physically permanent archival infrastructure for the age of AI. By combining the scaling laws of the semiconductor industry with the density of synthetic biology, Mimulus solves the global archival storage crisis and liberates critical grid power for AI compute. Led by a team of serial entrepreneurs with

More news about: GenScript Biotech Corporation


Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era

physically permanent archival infrastructure for the age of AI. By combining the scaling laws of the semiconductor industry with the density of synthetic biology, Mimulus solves the global archival storage crisis and liberates critical grid power for AI compute. Led by a team of serial entrepreneurs with

More news about: GenScript Biotech Corporation


Apr 09, 2026, 03:53 ET Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33.21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence

https://www.mordorintelligence.com/industry-reports/synthetic-biology-market?utm_source=prnewswireSynthetic Biology Market Competitive OutlookThe synthetic biology market features a mix of biotechnology companies, research

More news about: Mordor Intelligence Private Limited


Apr 07, 2026, 15:43 ET LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market

Biotechnologies is a U.S.-based biomanufacturer redefining how the world produces specialty chemicals and ingredients. Through precision fermentation and synthetic biology, DMC creates sustainable, bio-based alternatives that reduce carbon emissions, enhance quality, and improve global supply chain resilience. The

More news about: LBB Specialties LLC